Spyre Therapeutics Inc (FRA:3920)
€ 23.2 0.2 (0.86%) Market Cap: 1.40 Bil Enterprise Value: 1.25 Bil PE Ratio: 0 PB Ratio: 7.32 GF Score: 49/100

Spyre Therapeutics Inc (FRA:3920) Transcripts

  • 1